Merging CHEMISTRY AND BIOLOGY TO BENEFIT THE LIVES OF PATIENTS
Dr. Pia Challita-Eid
Dr. Alexander Chu-Kung
Alexander Chu-Kung is the Vice President of CMC at Adcentrx Therapeutics. Prior to joining Adcentrx, Dr Chu-Kung was the Senior Director of Development at Levena Biopharma, a subsidiary of Sorrento Therapeutics where he was responsible for all aspects of process development, cGMP manufacturing and clinical supply of the antibody drug conjugate pipeline.